J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 88 (2007), 2003-2012; DOI 10.1099/vir.0.82633-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, H. S.
Right arrow Articles by Lee, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, H. S.
Right arrow Articles by Lee, H.
Agricola
Right arrow Articles by Lee, H. S.
Right arrow Articles by Lee, H.

Universal and mutation-resistant anti-enteroviral activity: potency of small interfering RNA complementary to the conserved cis-acting replication element within the enterovirus coding region

Hui Sun Lee1,2,{dagger}, Jeonghyun Ahn1,2,{dagger}, Youngmee Jee3, Il Sun Seo1,2, Eun Jung Jeon1,2, Eun-Seok Jeon4,5, Chul Hyun Joo1,2, Yoo Kyum Kim1,2 and Heuiran Lee1,2,{ddagger}

1 Department of Microbiology, University of Ulsan College of Medicine, Seoul, Korea
2 Research Institute for Biomacromolecules, University of Ulsan College of Medicine, Seoul, Korea
3 Division of Enteric and Hepatitis Viruses, Department of Virology, National Institute of Health, Korea Center for Disease Control and Prevention, Seoul, Korea
4 Department of Internal Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea
5 Cardiac and Vascular Center, Samsung Medical Center, Seoul, Korea

Correspondence
Heuiran Lee
heuiran{at}amc.seoul.kr

The promising potential of RNA interference-based antiviral therapies has been well established. However, the antiviral efficacy is largely limited by genomic diversity and genetic instability of various viruses, including human enterovirus B (HEB). In this work, the first evidence supporting the anti-HEB activity of the small interfering RNA (siRNA) targeting the highly conserved cis-acting replication element (CRE) within virus coding region 2C is presented. HeLa cells pre-treated with siRNA complementary to the conserved sequence of the loop region of CRE(2C) were effectively rescued from the cytopathic effects of HEBs. Downregulation of virus replication and attenuation of cytotoxicity were consistently observed in various reference strains and clinical isolates. Cells treated with this siRNA were resistant to the emergence of viable escape mutants and showed sustained antiviral ability. Collectively, the data suggest that the siRNA based on the disordered structure within the highly conserved cis-acting coding region has potential as a universal, persistent anti-HEB agent. The same strategy can be successfully applied to the development of siRNA with consistent antiviral effects in other virus groups possessing similar RNA elements.

{dagger}These authors contributed equally to this work.

{ddagger}Present address: Department of Microbiology, University of Ulsan College of Medicine, Songpa PO Box 145, Seoul, Korea.




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
M. Nygardas, T. Vuorinen, A. P. Aalto, D. H. Bamford, and V. Hukkanen
Inhibition of coxsackievirus B3 and related enteroviruses by antiviral short interfering RNA pools produced using {phi}6 RNA-dependent RNA polymerase
J. Gen. Virol., October 1, 2009; 90(10): 2468 - 2473.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2007 by the Society for General Microbiology.